共 104 条
[1]
Weidner N(1992)Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma J Natl Cancer Inst 84 1875-1887
[2]
Folkman J(2004)Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis Cancer Res 64 2941-2955
[3]
Pozza F(2003)E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer Clin Breast Cancer 3 421-422
[4]
Uzzan B(2011)Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO Eur J Cancer 47 2387-2395
[5]
Nicolas P(2011)RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2–negative, locally recurrent or metastatic breast cancer J Clin Oncol 70 7042-7052
[6]
Cucherat M(2010)The sympathetic nervous system induces a metastatic switch in primary breast cancer Cancer Res 12 939-944
[7]
Perret GY(2006)Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma Nat Med 15 2042-2052
[8]
Miller KD(2008)Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis Ann Surg Oncol 29 2645-2652
[9]
Pivot X(2011)Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort Breast Cancer Res Treat 26 1781-1783
[10]
Schneeweiss A(2011)Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer J Clin Oncol 1 628-38